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Objectives Medication discrepancies for patients after
discharge from hospital are well documented. They have
been shown to cause unnecessary harm to patients and
can result in hospital readmission. To improve patient
discharge, the current process of discharging patients
from hospital (the discharge process) needs evaluating to
determine where and why medication issues occur. This
study aimed to identify and evaluate the discharge
process used in a range of acute National Health Service
hospitals across the North West of England.
Methods This qualitative study involved
semi-structured telephone interviews with 13 chief
pharmacists or an appropriately nominated member of
the hospital pharmacy team. Thematic analysis of the
transcribed interview data was performed. Data analysis
revealed eight main themes which all impacted on the
discharge process.
Results The study was successful in identifying the
discharge process across the range of hospitals as well
as key issues and examples of good practice. The
hospitals involved in the study were found to have
similar discharge processes with issues common to all.
One signiﬁcant ﬁnding was a lack of patient involvement
in the discharge process.
Conclusions To improve the patient discharge process,
innovative solutions are required to overcome the current
issues. In future work, the study ﬁndings will be used to




Discharging patients from acute NHS hospitals is a
complex process which involves various members
of the multidisciplinary team.1 Good coordination
and communication between the healthcare provi-
ders involved is essential to ensure that patients are
discharged safely with robust ongoing care.
Discharge can involve a variety of health and social
care aspects depending on individual patient needs.
A complete description of all aspects of the dis-
charge process is beyond the scope of this paper,
which will focus on the issues surrounding the
process of medication supply at discharge and
during transfer of care to the community.
The supply of medication at discharge begins
with the creation of a discharge prescription which
is commonly referred to as ‘To Take Out’ (TTO).
The TTO is a complete and accurate list of all
medication the patient should take after discharge
from hospital. A typical discharge process involves
a doctor writing a TTO for a patient which is then
checked by a pharmacist. Any medication needed is
dispensed by the hospital pharmacy based on this
TTO. The nurse looking after the patient will
check the medication against the TTO before
giving them to the patient along with the discharge
summary.
Transfer of care to the community involves the
discharge summary, including the TTO, being sent
to the patient’s general practitioner (GP) within
24 hours of patient discharge. Providing a complete
and accurate discharge summary aids the transfer of
care from hospital into the community and allows
the GP to coordinate appropriate ongoing care.1
It is essential that the discharge summary contains
all relevant information regarding the episode of
hospital care. In an attempt to promote uniformity
of content there are published standards detailing
the necessary information to include in a discharge
summary.2 3
Another aspect of transfer of care into the com-
munity is the role of the community pharmacist in
assisting patients discharged on medication.
Research in the late 1990s found that providing
community pharmacists with a copy of patient dis-
charge summaries was an effective method of redu-
cing unintentional medication discrepancies.4
Further research has demonstrated the value of the
community pharmacist in separating old and new
medications, disposing of any unnecessary medica-
tion, counselling patients and answering
medicine-related questions,5 ensuring continuity
and quality of patient care during the discharge
process.6–9 More recently, community pharmacies
can offer the New Medicine Service (NMS) and
Medicines Use Reviews (MURs) to support patients
recently discharged and improve transfer of care
between the hospital and community.10 The NMS
involves a community pharmacist assessing adher-
ence and identifying problems with certain newly
prescribed medication. MURs are an in-depth
review of a patient’s medication to ensure they
understand how and when to use their medicines.10
There are four target groups of patients for which
MURs are aimed, which are based on their medi-
cines or clinical condition. One of these target
groups is patients recently discharged from hospital
with changes to their medicines.11 Despite the
availability of evidence-based community pharma-
cist services, studies show that uptake of discharge
medication reviews is limited.12 Evidence also sug-
gests that a lack of communication between hos-
pital pharmacists and community pharmacists is
common.13 14 In the main, community pharmacists
are not aware that their patients have been into
hospital.15
Discharge from hospital is known to be fraught
with issues. It is a time consuming process often
resulting in patients waiting for their medicines and
temporarily blocking beds.16 In particular, medica-
tion discrepancies are common at discharge. A sig-
niﬁcant percentage of older patients experience
medication discrepancies after transferring from


































































































































hospital to home,17 leading to medication errors. Medication
errors can cause unnecessary harm to patients and can result in
readmission to hospital.18 According to a 2014 report, prevent-
able harm from medicines is thought to cost the NHS anywhere
between £1 billion and £2.5 billion annually.19 A number of
factors are thought to contribute to medication discrepancies
after hospital discharge,13 14 including incomplete information
on discharge summaries sent to GPs,13 14 20 21 lack of prompt
transfer of information to a patient’s GP13 14 21 22 and lack of
patient understanding of discharge instructions.13 14 23
As discussed, hospital discharge can result in a variety of pro-
blems affecting patients and hospitals. It is important to deter-
mine how and where in the process these problems arise.
Additionally, despite the well-documented problems associated
with discharge, little is known about solutions developed by
hospitals to address these problems. This study attempts to
broaden the literature on this topic by investigating the dis-
charge process at a range of hospitals.
AIM
To identify and evaluate the discharge process used in a range of
acute National Health Service (NHS) hospitals across the North
West of England.
METHOD
This qualitative study involved semi-structured telephone inter-
views with participants from acute NHS hospitals across North
West England. Participants from specialist hospitals such as chil-
dren’s and mental health trusts were excluded because their dis-
charge process is likely to be tailored to that specialty and may
not be relevant to an acute general hospital.
Participants who met the inclusion criteria were either chief
pharmacists or an appropriately nominated senior member of
pharmacy staff with knowledge of the discharge process from
each of the 22 acute NHS hospitals across North West England.
Each potential participant was sent an introductory invitation
via their NHS hospital email account outlining the study and
consent form. This was a convenience sample of experts and all
those who responded were included in the study.
The interview schedule consisted of closed questions collect-
ing demographic information and open-ended questions about
the discharge process. The participants were asked to describe
the discharge process in their hospital and were probed for
more detail and prompted to express their experiences, prior-
ities and concerns throughout the interview. No topics were dis-
cussed that any of the participants found distressing during the
interviews. Telephone interviews were recorded. Data collection
continued until data saturation was achieved.
The audio-recorded interviews were transcribed by the
researcher and checked to ensure content and meaning was
maintained. All data were anonymised at the transcription stage
by removing participant identiﬁable information. Thematic ana-
lysis was used to analyse the data using NVivo 10 software to
code transcripts.
A pilot study was undertaken with two pharmacists to verify
the recruitment procedure and the interview schedule prior to
commencing data collection. No signiﬁcant amendments were
required as a result of the pilot.
RESULTS
Thirteen telephone interviews (average duration 30 min, range
15–50 min) were conducted between January and April 2015.
Participants included nine chief pharmacists, three clinical ser-
vices managers and one technical ward-based services manager.
The participants were from a range of hospitals: six large teach-
ing hospitals, six district general hospitals and one integrated
care organisation.
Eight main themes emerged from the data analysis. The
salient points from each theme are discussed below. The anon-
ymised quotes in the themes that follow are annotated with the
type of hospital in which the interviewee was employed.
Main Q1themes
Planning for discharge
Discharge planning was taking place, but patient discharge was
thought to be poorly coordinated.
So no-one coordinates it most of the time, although there’s lots
of attempts to coordinate it. (large district general hospital)
Another issue was that, although most patients are discharged
within pharmacy working hours, there were some exceptional
circumstances where patients were discharged out of hours.
Problems occur when the pharmacist is not available to com-
plete discharge prescriptions out of hours which can lead to
patient safety issues.
Discharge documentation
All of the hospitals in the study used electronic discharge
systems, despite some not using electronic prescribing systems.
Electronic discharge allows hospitals to send discharge summar-
ies to GPs within the current target of 24 hours. The hospitals
participating in the study were mostly compliant with current
standards2 3 by including relevant information in the discharge
summary template. However, issues regarding incomplete dis-
charge summaries were highlighted by several of the participants
during the interviews.
Obviously it’s garbage in garbage out, you ﬁnd individual doctors
not doing a very good job on the discharge summary, but this
tends to be the minority (small district general hospital)
Preparing the discharge prescription and summary for an
inpatient episode is traditionally carried out by the junior
doctor involved in a patient’s care during their admission.24
This study showed further evidence of this as common practice.
Participants agreed that writing the discharge prescription was
not a priority for doctors and often took too long.
Verifying the discharge prescription to ensure medication pre-
scribed at discharge is accurate, safe and includes all the
required information was seen as an important stage in the dis-
charge process. Participants had audit data demonstrating that
the pharmacist clinical check signiﬁcantly reduces medication
discrepancies on discharge prescriptions. A patient safety issue
was identiﬁed for discharge prescriptions sent out without a
pharmacist’s review.
Supply of medication for discharge
Despite guidance to help reduce medication waste at hospital
discharge,25 26 participants found that the supply of medication
at discharge from hospital was highlighted as an area of waste in
terms of cost and time.
Dispensing the required medication for discharge traditionally
takes place in the pharmacy dispensary. However, the majority
of hospitals now also have facilities for the ward-based phar-
macy team to dispense medication for discharge at ward level.
Participants had evidence demonstrating that providing ward-
based dispensing had reduced the wait time for patients com-
pared with sending the TTO to the pharmacy, which is in line
with current evidence.13


































































































































Post-discharge community pharmacy involvement
Despite current recommendations that, for a successful dis-
charge service, communication should include community phar-
macists,13 it was uncommon for information to be sent to the
community pharmacy by the hospitals involved in the study.
Findings suggest that this usually only occurs if a patient has
their medication supplied in a multi-compartment compliance
aid by a regular community pharmacy.
Few hospitals in the study refer patients to their community
pharmacy for MURs or NMS as is currently recommended.10
One hospital has developed an electronic application which
allows easy identiﬁcation of the patient’s local community phar-
macy and sends a referral, including patient’s discharge informa-
tion, to that pharmacy. The onus is then on the pharmacy to
contact the patient to provide an NMS or undertake an MUR.
Communication within the discharge process
Communication within the multidisciplinary team was consid-
ered important by participants in delivering quality patient care
in agreement with current evidence27 and in the planning and
organisation of care and the systems used. One participant felt
that the pharmacist should play a more integrated role in the
team in order to improve communication, add to the skill mix
of professionals and provide better patient care at discharge.
Overall, the use of technology to communicate within the dis-
charge process was seen as positive. The research showed vari-
ation between the hospitals in the extent and type of technology
being used. There were a variety of mechanisms for sending the
completed discharge summary to the GP, including: direct elec-
tronic transfer, email (via NHS.net email address) or by post.
Not all medical practices use electronic systems and the mechan-
ism to send completed discharge summaries depends on the
capabilities of the medical practice.
Factors affecting the discharge process
Throughout the interviews a variety of pressures impacting on
the discharge process were mentioned. This was often implicit,
as a reason for certain aspects of the discharge process not
running smoothly. Hospitals and staff are under pressure from a
variety of sources including meeting targets across the hospital,
meeting patient expectations and ensuring quality patient care is
provided within the constraints of staff time and resource.
Staff training was highlighted by participants as a factor
impacting on the discharge process. Many issues identiﬁed
throughout the discharge process resulted from a lack of staff
training. For example, in one hospital, improved training for
prescribers on the discharge process was a focus; speciﬁcally,
educating prescribers to prescribe earlier and how to complete
discharge summaries so that they contain all of the necessary
information to send to the GP. The lack of staff training high-
lighted was linked to the hospitals being under-resourced.
Patient involvement
Patients and their carers should be involved in planning for their
discharge in order to manage patient expectations and help
them understand potential complexities or issues.28 A signiﬁcant
ﬁnding from the study was that patients had limited involvement
in their own discharge from hospital. This was noted through-
out all interviews and supports ﬁndings from a recent report
showing that patients do not feel involved in decisions about
their care.29
Patient counselling should take place whenever any new medi-
cation is prescribed. It is important that the patient is counselled
on their medication by the point of discharge. All of the partici-
pants agreed that patients are not always counselled and that it
is unclear who is responsible for providing counselling.
Who counsels? That’s a good question. The answer is probably
we don’t, nobody does it well enough I’d say. It’s an area which
is poorly managed. I think doctors think nurses do it, nurses
think pharmacists do it and pharmacists think everybody else
does it apart from them. I think pharmacists do it to a certain
extent, but not universally and comprehensively. It is an area for
development still
(small district general hospital)
Participants had anecdotal evidence that, when a patient is
medically ﬁt for discharge, doctors tell the patient that they can
go home without giving a realistic timescale of how long the
process will take. This poor communication gives patients unreal-
istic expectations that they can leave straight away, which is often
not the case and will impact on their experience in hospital.
Innovative discharge processes
Patients have high expectations of the services provided to them
by the NHS.30 In order to address the issues of high pressures
and meeting patient expectations, hospitals have developed
innovative solutions to issues with the discharge process. This
theme—innovative discharge processes—focused on innovative
solutions to issues with the discharge process used by the
hospitals.
Pharmacists writing discharge prescriptions in place of junior
doctors had been piloted in several hospitals. As a result, partici-
pants had data to show that this reduced the time taken to
obtain a written discharge prescription and also improved their
accuracy. Several hospitals in the study had access to
pharmacy-led community interface teams who visit patients after
discharge. Patients are referred to the teams if they need help
with their medication or are high risk for readmission. There is
anecdotal evidence that this support is beneﬁcial for patients.
One innovative technology solution currently used in one
hospital is an Integrated Care Record which allows healthcare
professionals to input and obtain patient information from both
sides of the interface—hospital and medical practices.
An important ﬁnding from the study suggested innovative work
thought to improve the discharge process has been piloted in hos-
pitals for over 10 years16 but not developed into routine practice
across all hospitals. Participants cited difﬁculties in obtaining
funding as a reason for struggling to provide new services.
Generalised discharge process model
From the ﬁndings, a generalised discharge process has been
identiﬁed. This is displayed in ﬁgure 1 in the form of a ﬂow-
chart representing the stages involved in the discharge process
for the hospitals in the study. For most hospitals this is an accur-
ate description of the process. Individual hospitals may show
minor variance from this generalised model. The shaded areas
in the ﬂowchart represent those stages in the discharge process
where problems were identiﬁed by the thematic analysis.
Limitations and further work
As with all qualitative research, a limitation of the study was the
inherent risk of personal bias from the researcher because of
their role as a hospital pharmacist. In an attempt to reduce this
risk, all analysis was grounded in the data. Despite the range of
hospitals involved in the study, a limited sample speciﬁc to the
North West of England was used. As a result, the ﬁndings are


































































































































not generalisable to other regions and there may be variations in
the discharge process across the UK.
The research was intentionally developed to gain a deep
understanding of the discharge process from an operational per-
spective. As a result of this, the study provided a limited insight
into the patients’ perspective. The lack of patient involvement
in the process was demonstrated, particularly with regard to
communication and counselling. In view of this ﬁnding, further
work is being undertaken to assess the discharge process from
the patients’ perspective.
This study forms part of a larger research project to develop a
new model of care for the discharge of patients from hospital
back into the community, with the aim of providing quality care
across the interface. The study ﬁndings, both positive and nega-
tive, will be used to inform the development of a new model
for the discharge process.
Figure 1 Generalised discharge process with shaded steps indicating where issues were thought to arise during discharge.



































































































































This study is the ﬁrst to identify and evaluate the discharge
process in acute NHS hospitals across North West England. This
research has identiﬁed that the hospitals in the study operate
similar discharge processes. Furthermore, the ﬁndings revealed
areas of the discharge process that worked well and highlighted
areas where problems exist and their causes. This study builds
on the existing knowledge of issues at discharge.
The study highlighted a number of signiﬁcant ﬁndings, such
as lack of staff training on patient discharge, lack of patient
involvement in the discharge process and poor communication
between hospital and community pharmacists.
Many of the problems highlighted by the study are longstand-
ing and attempts have been made to overcome them. Most of the
innovative solutions to these problems suggested by the partici-
pants were based on small-scale pilots and have not become part
of routine practice. A new model of care is required to improve
patient discharge from hospital, overcoming the current issues.
Key messages
What is already known on this subject
▸ Medication problems for patients after hospital discharge are
well documented and can result in patient harm and
hospital readmissions.
▸ It is important to determine where and why problems arise
in the discharge process in order to improve patient
discharge.
What this study adds
▸ A generalised discharge model has been described, along
with common issues and examples of good practice, for
acute NHS hospitals across North West England.
▸ Despite attempts to overcome problems at discharge, issues
still arise and innovative solutions are required to improve
patient discharge.
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